TELA Bio, Inc. Quarterly Interest Expense in USD from Q3 2018 to Q1 2024

Taxonomy & unit: us-gaap: USD
Description: Amount of the cost of borrowed funds accounted for as interest expense.
Summary: TELA Bio, Inc. quarterly/annual Interest Expense history and growth rate from Q3 2018 to Q1 2024.
TELA Bio, Inc. Interest Expense for the quarter ending March 31, 2024 was $1.33M, a 6.9% increase year-over-year.
TELA Bio, Inc. Interest Expense for the twelve months ending March 31, 2024 was $5.31M, a 21% increase year-over-year.
TELA Bio, Inc. annual Interest Expense for 2023 was $5.22M, a 28.9% increase from 2022.
TELA Bio, Inc. annual Interest Expense for 2022 was $4.05M, a 12.6% increase from 2021.
TELA Bio, Inc. annual Interest Expense for 2021 was $3.6M, a 0.93% increase from 2020.

Interest Expense, Trailing 12 Months (USD)

Interest Expense, Quarterly (USD)

Interest Expense, YoY Quarterly Growth (%)

Period	TTM Value	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed
Q1 2024	$5.31M	$1.33M	+$86K	+6.9%	Jan 1, 2024	Mar 31, 2024	10-Q	2024-05-10
Q4 2023	$5.22M	$1.35M	+$171K	+14.6%	Oct 1, 2023	Dec 31, 2023	10-K	2024-03-22
Q3 2023	$5.05M	$1.33M	+$302K	+29.3%	Jul 1, 2023	Sep 30, 2023	10-Q	2023-11-13
Q2 2023	$4.75M	$1.3M	+$364K	+39%	Apr 1, 2023	Jun 30, 2023	10-Q	2023-08-10
Q1 2023	$4.39M	$1.25M	+$335K	+36.8%	Jan 1, 2023	Mar 31, 2023	10-Q	2024-05-10
Q4 2022	$4.05M	$1.17M	+$252K	+27.3%	Oct 1, 2022	Dec 31, 2022	10-K	2024-03-22
Q3 2022	$3.8M	$1.03M	+$110K	+11.9%	Jul 1, 2022	Sep 30, 2022	10-Q	2023-11-13
Q2 2022	$3.69M	$934K	+$70K	+8.1%	Apr 1, 2022	Jun 30, 2022	10-Q	2023-08-10
Q1 2022	$3.62M	$911K	+$22K	+2.48%	Jan 1, 2022	Mar 31, 2022	10-Q	2023-05-11
Q4 2021	$3.6M	$922K	+$19K	+2.1%	Oct 1, 2021	Dec 31, 2021	10-K	2024-03-22
Q3 2021	$3.58M	$922K	+$24K	+2.67%	Jul 1, 2021	Sep 30, 2021	10-Q	2022-11-10
Q2 2021	$3.55M	$864K	-$20K	-2.26%	Apr 1, 2021	Jun 30, 2021	10-Q	2022-08-11
Q1 2021	$3.57M	$889K	+$10K	+1.14%	Jan 1, 2021	Mar 31, 2021	10-Q	2022-05-11
Q4 2020	$3.56M	$903K	+$19K	+2.15%	Oct 1, 2020	Dec 31, 2020	10-K	2023-03-23
Q3 2020	$3.55M	$898K	-$1K	-0.11%	Jul 1, 2020	Sep 30, 2020	10-Q	2021-11-12
Q2 2020	$3.55M	$884K	-$30K	-3.28%	Apr 1, 2020	Jun 30, 2020	10-Q	2021-08-12
Q1 2020	$3.58M	$879K	-$33K	-3.62%	Jan 1, 2020	Mar 31, 2020	10-Q	2021-05-14
Q4 2019	$3.61M	$884K			Oct 1, 2019	Dec 31, 2019	10-K	2022-03-23
Q3 2019		$899K	+$590K	+191%	Jul 1, 2019	Sep 30, 2019	10-Q	2020-11-12
Q2 2019		$914K			Apr 1, 2019	Jun 30, 2019	10-Q	2020-08-13
Q1 2019		$912K			Jan 1, 2019	Mar 31, 2019	10-Q	2020-05-15
Q3 2018		$309K			Jul 1, 2018	Sep 30, 2018	10-Q	2019-12-18

* An asterisk sign (*) next to the value indicates that the value is likely invalid.